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Abstract
Candida bloodstream infection, i.e. candidemia, is the most frequently encountered life-
threatening fungal infection worldwide, with mortality rates up to almost 50%. In the majority
of candidemia cases, Candida albicans is responsible. Worryingly, a global increase in the
number of patients who are susceptible to infection (e.g. immunocompromised patients),
has led to a rise in the incidence of candidemia in the last few decades. Therefore, a better
understanding of the anti-Candida host response is essential to overcome this poor progno-
sis and to lower disease incidence. Here, we integrated genome-wide association studies
with bulk and single-cell transcriptomic analyses of immune cells stimulated with Candida
albicans to further our understanding of the anti-Candida host response. We show that dif-
ferential expression analysis upon Candida stimulation in single-cell expression data can
reveal the important cell types involved in the host response against Candida. This con-
firmed the known major role of monocytes, but more interestingly, also uncovered an impor-
tant role for NK cells. Moreover, combining the power of bulk RNA-seq with the high
resolution of single-cell RNA-seq data led to the identification of 27 Candida-response QTLs
and revealed the cell types potentially involved herein. Integration of these response QTLs
with a GWAS on candidemia susceptibility uncovered a potential new role for LY86 in candi-
demia susceptibility. Finally, experimental follow-up confirmed that LY86 knockdown results
in reduced monocyte migration towards the chemokine MCP-1, thereby implying that this
reduced migration may underlie the increased susceptibility to candidemia. Altogether, our
integrative systems genetics approach identifies previously unknown mechanisms underly-
ing the immune response to Candida infection.
PLOS PATHOGENS
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Author summary
Candida albicans is a fungus that can cause a life-threatening infection in individuals with
an impaired immune system. To improve the prognosis and treatment of patients with
such an infection, a better understanding of an individual’s immune response against
Candida is required. However, small patient group sizes have limited our ability to gain
such understanding. Here we show that integrating many different data layers can
improve the sensitivity to detect the effects of genetics on the response to Candida infec-
tion and the roles different immune cell types have herein. Using this approach, we were
able to prioritize genes that are associated with an increased risk of developing systemic
Candida infections. We expand on the gene with the strongest risk association, LY86, and
describe a potential mechanism through which this gene affects the immune response
against Candida infection. Through experimental follow-up, we provided additional
insights into how this gene is associated with an increased risk to develop a Candida infec-
tion. We expect that our approach can be generalized to other infectious diseases for
which small patient group sizes have restricted our ability to unravel the disease mecha-
nism in more detail. This will provide new opportunities to identify treatment targets in
the future.
Introduction
Candida albicans (C. albicans) is an opportunistic fungus colonizing the skin and/or mucosae
of approximately 70% of the population [1]. Disruption of the mucosal barrier or a compro-
mised immune system of the host can increase susceptibility to Candida infections. This
makes it the most common cause of hospital-acquired invasive fungal infections globally [2],
with high mortality rates between 33% and 46% [3,4]. The most common form of invasive can-
didiasis occurs in the blood, known as candidemia [2]. Despite the severity of candidemia and
its accompanying research interest, the ability to improve the outcomes for affected individuals
has stagnated in recent years. Adjuvant immunotherapy has been suggested as an important
strategy to improve patient outcomes, but to implement this a better understanding of the
immune response to Candida is required [5,6]. As genetics have a great impact on an individu-
al’s immune response [7], knowledge on its impact to the anti-Candida response will be
important as well for the implementation of such therapies.
Genome-wide association studies (GWAS), linking genetic variants to disease risk, have
been a commonly used approach to increase disease understanding. However, in the context
of candidemia and other infectious diseases, conducting a GWAS is challenging due to the lim-
ited size of patient cohorts [8]. Moreover, GWAS studies provide limited insight into the
underlying biology of how these genetic variants are linked to Candida infection susceptibility.
Thus additional approaches are required.
Integrative strategies that combine different molecular datasets in the context of Candida
infection have been suggested as alternative approaches to prioritize cell types, genes and path-
ways. These can then be used for follow-up functional studies to better understand candidemia
susceptibility. For instance, Smeekens et al. integrated gene expression array data of Candida-
stimulated PBMCs with genetic information and cytokine measurements from both healthy
volunteers and patients with increased susceptibility to Candida infections [9]. Using this inte-
grative approach, they identified the interferon pathway as being a crucial host response path-
way against Candida infection. In a follow-up study, the additive value of integrating multiple
molecular datasets became even more apparent as suggestive genetic associations together
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with transcriptomic data could prioritize novel pathways implicated in candidemia susceptibil-
ity, including the complement and hemostasis pathways [10].
However, further integration is required to understand the mechanism through which
genetic variants lead to increased candidemia-susceptibility. These disease-associated variants
can be linked to effects on gene expression levels through so-called expression quantitative
trait loci (eQTL) analysis. Since disease-associated genetic variants are often regulated in a
context-specific manner [11], such eQTL analyses should be performed in such a way that the
context-specific nature, i.e. pathogen- and cell type-specificity, can be revealed. With the
advent of single-cell RNA-sequencing (scRNA-seq) it now becomes possible to profile the
expression of tens of thousands of individual cells at the same time in an unbiased manner
[12]. This now allows capturing the context-specific nature of disease-associated genetic vari-
ants with increased resolution, while retaining the intercellular dynamics.
Here, we used an integrative approach combining GWAS with bulk and scRNA-seq tran-
scriptomic analyses on Candida-stimulated and RPMI control peripheral blood mononuclear
cells (PBMCs). By leveraging the sensitivity of bulk RNA-seq data with the context-specific
information acquired from scRNA-seq, this integrative approach further improves our under-
standing of the host response against Candida.
Results and discussion
Cell type-specific transcriptional response to Candida albicans
To reveal the cell type-specific immune response against Candida, scRNA-seq analysis was
performed on PBMCs from 6 individuals that were stimulated with Candida or RPMI control
for 24h. After QC, a total of 15,085 cells remained, of which 7,925 cells were RPMI control and
7,160 cells were Candida-stimulated. These cells were classified as one of the following six
immune cell types: B cells, CD4+ T cells, CD8+ T cells, monocytes, natural killer (NK) cells or
plasmacytoid dendritic cells (pDC).
As pathogen-stimulation can potentially affect the cellular state or induce active recruit-
ment of specific cell types, we first determined whether Candida-stimulation affected the rela-
tive abundance of immune cell types. At baseline, the largest differences in relative abundance
of individual cell types varied between 1.6-fold for the CD4+ T cells up to 8.3-fold for the CD8+
T cells (S1 Fig). However, upon stimulation these abundances remained constant within an
individual. Overall, CD4+ T cells were the most abundant cell type (61.2%), whereas pDCs
were observed the least (1.3%) (Table 1). Even though changes in relative abundances were not
detected, we cannot exclude that this is not happening in vivo, as our in vitro stimulation of
PBMCs does not allow detection of active recruitment. Active recruitment of monocytes
towards the lymph nodes is part of the host immune response towards Candida, as recently
shown in mice [13].
Secondly, we identified differentially expressed (DE) genes upon stimulation per cell type
separately as well as in all cells together (bulk-like) by performing DE analysis with MAST
[14]. This analysis identified a total of 2,384 DE genes in the individual cell types and 3,568 DE
genes in the bulk-like sample (Table 1, S1 Table). However, the noisiness and sparseness of sin-
gle-cell data could potentially introduce artifacts in the DE analysis, resulting in false-positives
[15]. To determine the extent to which this occurs, we compared the DE genes identified in
the scRNA-seq data with their differential response in a previously described bulk RNA-seq
dataset generated from Candida-stimulated PBMCs isolated from 70 individuals [7]. This
comparison showed that 97.3% of the DE genes from the bulk-like scRNA-seq sample (Fig
1A-I) and at least 96.8% of the DE genes from the individual cell types (Fig 1A-II-VII) could
be replicated in the bulk-RNA seq data (S1 Table). Thus, the DE genes identified in scRNA-
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seq data reflect true biology rather than artifacts and can be used to uncover the cell type-spe-
cific immune response against Candida. However, please note that during this prolonged incu-
bation of 24h, it is not possible to distinguish between direct and indirect responses upon
Candida stimulation.
Candida induces large gene expression differences in CD4+ T cells, NK
cells and monocytes
Continuing with the 2,384 DE genes identified in the individual cell types (Fig 1B, S2 Table),
we found that 71% of these genes are being upregulated upon stimulation. The majority of
these DE genes (1,364) are only found in one cell type, of which the largest part in CD4+ T
cells, NK cells and monocytes (558, 468 and 304 DE genes, respectively). The remaining three
cell types have very few uniquely identified DE genes, with 27, 5 and 2 DE genes for B cells,
CD8+ T cells and pDCs, respectively. As the power to detect DE genes for a cell type is strongly
correlated with the number of cells for that particular cell type (Pearson correlation = 0.71)
(Panel A in S2 Fig), part of these differences can be attributed to differences in cell numbers
(Table 1). However, even when taking this into account, a disproportionately large number of
DE genes are specifically identified in the monocytes and NK cells (Panel B in S2 Fig).
To follow-up on these findings, we determined whether the connectivity between each of
the major cell types changed upon stimulation with Candida. For this, we calculated for each
cell type their potential to interact with cells from the same or another cell type by analyzing
the expression of cell type-specific receptor and ligand pairs per condition (Candida-stimu-
lated and RPMI control), using the computational framework CellPhoneDB [16]. This analysis
revealed that especially the B cells (on average 1.67-fold increase) and NK cells (on average
1.62-fold increase) gain additional potential cell-cell interactions upon stimulation with Can-
dida (Fig 1C, S3 Table).
Previous studies have reached a consensus that monocytes play an important role in candi-
demia [17,18], but the contribution of NK cells is less clear [19,20]. Interestingly, specifically in
immunocompromised mice the depletion of NK cells increased the susceptibility to candide-
mia [21]. As in humans, candidemia mainly affects immunocompromised patients, we
hypothesize that NK cells are likely to play an important role in the human candidemia
response as well. Through the DE and ligand-receptor expression analysis we show that, in
addition to monocytes, also NK cells are strongly activated and are increasingly connected to
other cells. This provides extra evidence for their importance in the immune response against
Candida.
In addition to these unique responses, 1,020 DE genes were identified across multiple cell
types, of which a core of 41 DE genes was shared between all six cell types. Of these shared DE
genes, 89.8% of effects have the same direction across all responding cell types (Fig 1D).
Table 1. Differentially expressed genes per cell type within PBMC single-cell RNA-seq data.
Cell type # cells # DE genes # up-regulated # down-regulated
CD4+ T 9,236 1,459 1,095 364
CD8+ T 2,300 453 334 119
NK 1,807 1,313 927 386
B 789 392 329 63
Monocyte 757 767 418 349
pDC 196 56 49 7
DE, differentially expressed; NK, natural killer cell; pDC, plasmacytoid dendritic cell; PBMC, peripheral blood mononuclear cell.
https://doi.org/10.1371/journal.ppat.1008408.t001
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Fig 1. Single-cell RNA-seq differential expression analysis reveals the cell type-specific response to Candida stimulation. (A) Comparison of differentially expressed
(DE) genes upon Candida stimulation identified in 6 individuals for whom single-cell RNA-seq (scRNA-seq) data is generated (y-axis) as compared to the effect in 70
bulk RNA-seq samples (x-axis). Each dot represents a DE gene and the dotted red lines indicate the significance thresholds. In panel I (DE genes in bulk-like scRNA-seq
sample, which contains all cells from an individual), concordant DE genes are shown in the green area and discordant genes in the red area. In panels II-VII (DE genes
in specific cell type), color indicates whether a DE gene is cell type-specific. (B) Bar plot showing the sharedness of DE genes across cell types. The first bar, with cell
type-specific DE genes, is colored based on the cell type in which the DE gene is found. (C) Heatmap of the total number of ligand-receptor interactions between cells of
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Moreover, these shared DE genes showed the strongest differential effect upon stimulation
(Fig 1D). Pathway analysis on the core set of 41 DE genes revealed strong enrichment of the
interferon pathway (P = 10-22) (S2 Table). This is in line with previous findings in PBMC bulk
expression data that showed strong differential expression of the interferon pathway upon 24h
Candida stimulation [9]. Notably, when taking the average expression of all interferon path-
way-associated genes per cell, the strength of upregulation of the interferon I pathway after
Candida stimulation is consistent across all cell types (Fig 1E).
Identification of Candida-response QTLs using bulk RNA sequencing
In addition to identifying cell type-specific responses to Candida infection, we also studied the
effect of genetic variants on gene expression levels before and after Candida stimulation using
previously published bulk RNA-seq data from PBMCs [7]. The rather small sample size of this
study limits its predictive power, in part by the large multiple testing burden of genome-wide
eQTL analysis [22]. To reduce the multiple testing burden, we limited our single nucleotide
polymorphism (SNP)-gene combinations to only the 16,990 top cis SNP-gene pairs identified
in the largest eQTL meta-analysis to date [23], containing unstimulated whole blood samples
of 31,684 individuals. However, by confining our analysis only to previously reported cis-
eQTLs in unstimulated blood samples, we might miss out on eQTLs that only show up after
stimulation. Nevertheless, if there is a weak effect without stimulation that is strengthened by
Candida stimulation, restricting ourselves to previously identified top SNP-gene pairs will
increase our chance to detect the eQTL effect. Using this approach, a total of 1,563 and 1,637
eQTLs were found in 72 Candida-stimulated and 75 RPMI control samples, respectively (Fig
2A, S4 Table). Whilst many (44%) of these eQTLs were found both before and after stimula-
tion, the majority of eQTLs were condition-specific (Fig 2A). By subtracting per individual
and per gene the Candida-stimulated expression from the RPMI control expression, we also
tested whether certain SNPs affected the expression of a particular gene with different effect
sizes before and after stimulation. This so-called response QTL analysis was performed in the
67 individuals for which both Candida-stimulated and RPMI control conditions were assessed
and revealed 27 response QTLs (S4 Table). Subsequently, scRNA-seq data was used to pin-
point the potential cell type in which the response QTL effects manifest themselves (S3 Fig).
Annotation of the cell type- and context-specificity of eQTLs may help to understand their
involvement in human disease.
Prioritization of LY86 as a potential key driver gene for candidemia
Previously, it was shown that integrating multiple molecular datasets can help prioritize dis-
ease-relevant genes, cell types and pathways [9,10]. Therefore, as a next step, we took the
GWAS summary statistics of a previously published candidemia cohort of 161 cases and 152
disease-matched controls [8] and overlaid this with our 27 response QTLs (Fig 2B). This
revealed an enrichment of candidemia-susceptibility SNPs within the Candida-response QTL
SNPs (ƛinflation = 1.49) (Fig 2C). The top enriched response QTL SNP was rs9405943 (P = 1.2 x
10−3, OR = 0.594), and was in near perfect linkage disequilibrium with rs2103635, the SNP
the same or different cell types. Each cell type is compared to cell types of the same condition (RPMI control left, 24h Candida-stimulation right). Each row has a
number showing the average fold enrichment in ligand-receptor pair interactions between that cell type and all cell types. (D) Heatmap of DE gene Z-scores per cell type
(y-axis) for genes that are identified as DE in more than one cell type (x-axis). Red colors indicate upregulation and blue colors show downregulation upon Candida
stimulation. Above the heatmap, genes found within the interferon pathway are highlighted. (E) Box plots showing the mean expression of interferon pathway-
associated genes (x-axis) for each cell type and stimulation condition (y-axis). Box plots show the median, first and third quartiles, and 1.5× the interquartile range and
each dot represents the expression of a single cell.
https://doi.org/10.1371/journal.ppat.1008408.g001
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showing the strongest association with candidemia in this region (P = 7 x 10−4, OR = 0.58) (r2
= 0.94) (S4 Fig). SNP rs9405943 showed a strong effect on expression levels of LY86 after Can-
dida stimulation (β = 0.58, P = 1.5 x 10−7), but not in the RPMI control condition (β = 0.05,
P = 0.68) (Fig 3A).
The expression of LY86 is strongly downregulated upon Candida stimulation in the bulk
RNA-seq dataset (P = 7.2 x 10−28). Additionally, we see that the candidemia-risk allele A at
rs9405943 is associated with stronger downregulation of LY86 after stimulation. This suggests
that high expression of LY86 has a protective function against candidemia. Single-cell gene
expression data shows that both B-cells and monocytes express LY86. However, only expres-
sion in monocytes is affected by the stimulation (P = 1.9 x 10−14) (Fig 3B and 3C), suggesting
that this gene contributes to candidemia susceptibility through monocytes.
It is known that LY86 forms a complex with Toll-like receptor protein RP105 and is
involved in several immune disorders [24–26]. Depending on the cell type, this complex has
opposite regulatory effects on TLR4 signaling [27,28]; while TLR4 signaling is activated and
stimulates proliferation and antibody production in B-cells, it is negatively regulated in mye-
loid cells. These opposite effects likely reflect the engagement of different cell type-specific co-
receptors [28]. While previous studies have shown the importance of the RP105/LY86 complex
in mediating the TLR4-mediated innate immune response against bacterial lipopolysaccha-
rides (LPS) [29,30], its role in the anti-Candida response is unknown.
In monocytes, both increased signaling activity of TLR4 and absence of RP105 are associ-
ated with downregulation of the chemokine receptor CCR2, leading to their reduced migra-
tory capacity [25,31]. Through complex formation with LY86, RP105 inhibits TLR4 signaling
in monocytes [28]. Therefore, we hypothesize that the rs9405943 candidemia-risk allele A,
which lowers LY86 expression in monocytes upon Candida stimulation, will decrease the
migratory capacity of monocytes, which ultimately increases susceptibility to candidemia (Fig
3D). In line with this, in mice the trafficking of CCR2-dependent inflammatory monocytes has
been shown to play an essential role in fungal clearance during systemic candidiasis in the first
48h of infection [18].
Fig 2. Integration of GWAS with eQTL analysis allows for prioritization of potential key driver genes. (A) Comparison of -log10 p-values of identified eQTLs in
individuals without Candida stimulation (n = 75) and eQTLs identified in individuals after Candida stimulation (n = 72). Red points show eQTLs that are significant
only with Candida stimulation, blue points show eQTLs that are significant only without Candida stimulation and black points depict eQTLs that are significant in both
conditions. The eQTL analysis was restricted to top SNP-gene combinations identified in the eQTLGen consortium [23]. (B) The performed work flow to identify
potential key driver genes in Candida response. (C) QQ-plot of 27 Candida-response QTL SNPs in a GWAS on candidemia susceptibility, comparing expected GWAS
P-values (x-axis) with observed GWAS P-values (y-axis). The dots show deviation from the expected line (ƛinflation = 1.49) with the strongest GWAS association found
for rs9405943.
https://doi.org/10.1371/journal.ppat.1008408.g002
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Of note, the TLR4 signaling pathway has been shown to be involved in the innate immune
responses of several microbial and fungal infections [32–35]. In addition, a previous study, in
which PBMCs from 8 individuals were stimulated for 24h with microbial and fungal patho-
gens, showed reduced expression of LY86 after stimulation withMycobacterium Tuberculosis
(-1.20-fold, P = 1.53 x 10−7), Borrelia (-1.34-fold, P = 7.31 x 10−13), Pseudomonas Aeruginosa
(-1.31-fold, P = 9.45 x 10−9) and Streptococcus Pseudomoniae (-1.54-fold, P = 2.01 x 10−19), but
not Aspergillus Fumigatus (-0.012-fold, P = 0.98) [7]. Altogether, this indicates that the differ-
ential regulation of LY86 in monocytes, as seen in response to Candida, could also affect the
susceptibility towards other blood-based bacterial infections.
Functional validation of the role of LY86 in monocytes
To test our hypothesized mechanism of action (Fig 3D), we conducted experimental follow-up
studies in THP-1 monocytes. As the candidemia risk allele in combination with Candida stim-
ulation is associated with reduced expression of LY86 specifically in the monocytes (Figs 2C
and 3A–3C), we used siRNA knockdown of LY86 to mimic this effect. 72h after siRNA treat-
ment, we confirmed efficient knockdown of LY86 (14.3-fold lower expression, P = 0.001) by
qPCR. In line with our hypothesis, the expression of CCR2 was also reduced (33.3-fold,
P = 0.0006) upon knockdown of LY86 (Fig 3E, S5 Table). These 72h LY86 or control siRNA
treated cells were then used in a migration assay to assess their migratory capacity towards the
chemokine MCP-1 or serum-free medium as a control. After 3h incubation, we only observed
migration towards MCP-1 and not the serum-free medium. Notably, the migratory capacity
towards MCP-1 of the LY86 siRNA treated cells was reduced (2.0-fold, P = 0.01) as compared
to control siRNA treated cells (Fig 3F, S5 Table). Summarized, these results indicate that
reduced expression of LY86 can reduce the migratory capacity of monocytes, potentially
through reduced expression of CCR2, and thereby, may increase the susceptibility to
candidemia.
Final discussion and conclusion
In summary, we present an integrative approach of GWAS, bulk RNA-seq and scRNA-seq
data to extract important knowledge about candidemia susceptibility. Such an integrative
approach is valuable in the context of infectious diseases, such as candidemia, for which the
limited size of patient cohorts limits the power of the GWAS. Otherwise, a GWAS alone would
require much larger sample sizes in order to extract useful information from such studies.
Moreover, a GWAS alone cannot explain how genetic variation affects disease or which cell
type will be affected, and therefore, a systematic integration of different molecular datasets
may be the only avenue to reveal this information. By combining these data layers, we
Fig 3. Proposed mechanism of LY86 in candidemia susceptibility. (A) Box plots showing the effect of rs9405943 genotype on LY86 expression
without Candida stimulation (left), after Candida stimulation (center) and the response difference to Candida stimulation (right), as calculated in
bulk RNA-seq data. Box plots show the median, first and third quartiles, and 1.5 × the interquartile range and each dot represents the expression of
an individual. The x-axis shows the rs9405943 genotype and the y-axis shows the expression or expression response difference for LY86. Red p-values
indicate significant effects. (B) A tSNE plot generated with single-cell expression data with and without Candida stimulation, colored by cell type. (C)
Two tSNE plots colored by the expression of LY86 (left) and CCR2 (right). Red cells indicate expression in a stimulated cell, blue cells indicate
expression in an unstimulated cell and gray cells have no expression. (D) The proposed working mechanism for LY86 on candidemia susceptibility
in monocytes. LY86 (aka MD-1) can form a complex with RP105 (aka CD180) and this complex directly binds to the LY96(aka MD-2)-TLR4
complex, thereby inhibiting TLR4 signaling. However, in individuals with the rs9405943 candidemia-risk allele, LY86-RP105 complex formation is
reduced, and as a result, LY96-TLR4 signaling is increased. As a consequence, TLR4-mediated chemokine receptor 2 (CCR2) repression increases,
which reduces monocyte recruitment towards MCP-1 (aka CCL2) and increases candidemia susceptibility. (E) Normalized LY86 and CCR2 gene
expression levels upon 72h LY86 siRNA or control siRNA treatment in THP-1 monocytes. Each bar represents the mean ± SD of three independent
experiments, ��� p< 0.001 (F) Migration rate of 72h LY86 versus control siRNA treated THP-1 cells towards MCP-1 or RPMI medium without
serum. Each bar represents the mean ± SD of three independent experiments, ��� p< 0.001.
https://doi.org/10.1371/journal.ppat.1008408.g003
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corroborate the previously identified importance of the IFN pathway and of monocytes in
Candida infections [9]. In addition, we provide new evidence for a strong response in NK cells
against Candida and a potential novel role for the LY86 gene in candidemia susceptibility.
Our integrative approach is not limited to Candida infection, but can also be applied to
gain a better insight into other infectious diseases for which the progress of disease under-
standing is hindered by small patient cohorts. We expect that in the near future, the cell type-
specific and context-specific resolution of this integrated approach can be further improved as
large-scale scRNA-seq datasets become readily available in many different individuals, stimu-
lation conditions and diseases through large-scale consortia such as the single-cell eQTLGen
(https://eqtlgen.org/single-cell.html) [36] and LifeTime consortium (https://lifetime-
fetflagship.eu). Such increased resolution would allow reconstruction of personalized, disease-
specific gene regulatory networks that could provide us with new insights that could guide
new treatment opportunities [37].
Materials and methods
PBMC collection and Candida-stimulation
Whole blood from 6 individuals of the northern Netherlands population cohort Lifelines Deep
[38] was drawn into EDTA-vacutainers (BD). PBMCs were isolated and maintained as previ-
ously described [39]. In short, PBMCs were isolated using Cell Preparation Tubes with sodium
heparin (BD) and were cryopreserved until use in RPMI 1640 containing 40% FCS and 10%
DMSO. After thawing and a 1h resting period, 50x104 cells were seeded in 200 μl RPMI1640
supplemented with 50 μg/mL gentamicin, 2 mM L-glutamine, and 1 mM pyruvate in a
nucleon sphere 96-round bottom well plate. Cells were either stimulated or kept unstimulated
for 24h with 1x106 heat-killed C. albicans blastoconidia (strain ATCC MYA-3573, UC 820)
CFU/ml at 37˚C in a 5% CO2 incubator. After 24h, cells were washed twice in medium supple-
mented with 0.04% bovine serum albumin. Cells were counted using a haemocytometer and
cell viability was assessed by Trypan Blue.
Single-cell library preparation and sequencing
Three, sex-balanced sample pools were prepared each aimed to contain 1750 cells/donor from
6 donors (10,500 cells). One pool contained only unstimulated cells, one pool only stimulated
cells and one pool contained a 50/50 mixture of both. Each sample pool was loaded into a dif-
ferent lane of a 10x chip (Single Cell A Chip Kit, 120236). The 10x Chromium controller (10x
Genomics) in combination with v2 reagents was used to capture the single cells and generate
sequencing libraries according to the manufacturer’s instructions (document CG00026) and
as previously described [39]. Sequencing was performed using the Illumina HiSeq 4000 with a
75-bp paired-end kit, performed by GenomeScan (Leiden, the Netherlands).
Single-cell RNA-seq alignment, preprocessing and QC
Alignment, demultiplexing and cell type classification of the scRNA-seq data was performed
as previously described [39], but now using the 2.3.0 version of Seurat [40]. After QC, 15,085
cells remained of which 7,160 were stimulated and 7,925 were unstimulated. The stimulated
and unstimulated cells were combined into a single dataset using Canonical Correlation Anal-
ysis (CCA) [40], by taking the first 20 dimensions. Clusters were identified using the FindClus-
ters function from Seurat, using the first 20 dimensions in the CCA space. Expression of
known marker genes was assessed to assign cell types to each cluster, resulting in the identifi-
cation of six major cell types.
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Single-cell RNA-seq differential expression analysis
Differential expression (DE) between Candida-stimulated and RPMI control cells was calcu-
lated for each cell type separately and in a bulk-like analysis using the MAST implementation
of the Seurat package [14]. All genes without expression in at least 1 cell were removed, leaving
20,236 genes. Bonferroni multiple testing correction was applied, yielding a significance
threshold of 2.47e-06. Genes that were differentially expressed in all cell types (i.e. core genes)
and each cell type individually were used as input for the ToppFun functional enrichment
analysis using the REACTOME pathway [41]. P-values were calculated using the probability
density function and were Bonferroni corrected.
Cell-to-cell interaction potential analysis
The potential of cell-to-cell communication through ligand/receptor pair interactions was
studied using version 2 of CellPhoneDB [16]. This software uses the normalized expression
data and the cell type classifications to see which cell types have expression of known ligands
and receptors to estimate whether there is an interaction potential between cells of the same or
different cell types. The analysis was performed on each cell type and condition (24h Candida-
stimulated versus RPMI control) separately. CellPhoneDB was run using the default database
of ligand-receptor interactions provided with the software and was run using default settings
for p-value thresholds (0.05), expression threshold (expression in > = 10% cells) and permuta-
tions (1,000).
Bulk RNA-seq data on Candida-stimulated PBMCs
All bulk RNA-seq data from PBMCs was previously generated [7] in 70 individuals from the
GONL cohort [42]. This data was generated from PBMCs that were stimulated for 24h with
Candida or remained unstimulated (RPMI control condition). Details of the stimulation are
similar to the scRNA-seq data on Candida-stimulated PBMCs as mentioned above, and have
been previously described [9]. The differentially expressed genes upon stimulation were previ-
ously identified [7] through DESeq2 [43]. The differential expressed genes identified in the
scRNA-seq data were compared with the differential response in this bulk RNA-seq data.
Bulk RNA-seq eQTL analysis
Of the same bulk RNA-seq cohort, eQTLs were identified in the data from 72 individuals and
75 individuals for Candida-stimulated and RPMI control conditions, respectively. The
response QTLs were identified in the 67 individuals for which both conditions were assessed
and genotype information is available. To calculate this, we subtracted per individual and per
gene the Candida-stimulated expression from the RPMI control expression and tested whether
certain SNPs affected the expression of a particular gene with different effect sizes before and
after stimulation. All expression data were log2 transformed before being used in the 1.2.4F
version of the QTL pipeline as described before [44]. To reduce the multiple testing burden,
analysis was restricted to the list of 16,989 top SNP-gene combinations identified in the largest
whole blood eQTL meta-analysis to date containing 31,684 whole blood samples [23]. This list
of top SNP-gene combinations contains SNPs with minor allele frequencies (MAF) >0.01,
Hardy-Weinberg P-values >0.0001, call rate >0.95, and MACH r2> 0.5 within a 1Mb win-
dow of the gene. An FDR threshold of 0.05 was used as significance cut-off, using the permuta-
tion strategy described in Westra et al. with 100 permutations [45].
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GWAS on candidemia susceptibility
The GWAS on candidemia susceptibility was previously described [8]. In short, this GWAS
was performed in a cohort of 161 candidemia cases and 152 disease-matched controls of Euro-
pean ancestry whose demographic and clinical characteristics have been previously described
[46]. DNA was genotyped using Illumina HumanCoreExome-12 v1.0 and HumanCoreEx-
ome-24 v1.0 BeadChip SNP chips. Genotypes were imputed using the human reference con-
sortium reference panel [47] using the Michigan imputation server [48]. In total, 5,426,313
SNPs were tested for disease association using Fisher’s exact test with PLINK v1.9 [49]. The
lambda inflation was calculated by taking the GWAS p-values for each of the 27 response-QTL
SNPs, regardless of whether the GWAS p-value was significant.
siRNA treatment
Before starting the experiment, THP-1 monocytes were maintained in RPMI medium supple-
mented with 10% FBS and 1% Pen-Strep at 37˚C in a humidified 5% CO2 incubator. 50,000
THP-1 monocytes were seeded in round-bottom 96-wells plates. During seeding, 1 μM Accell
human LY86 siRNA SMARTpool (Dharmacon) or 1 μM Accell Green non-targeting siRNA
control (Dharmacon) was delivered to these cells in 100 ul Accell delivery medium. After 24h,
this procedure was repeated by adding an additional 100 ul to each well. After 72h, LY86 and
CCR2mRNA levels were quantified using qRT-PCR and migration rate was quantified using a
migration assay.
Quantitative real-time PCR (qRT-PCR)
RNA was isolated using QIAzol lysis reagent according to manufacturer’s instructions. RNA
was quantified using a Nanodrop 1000 spectrophotometer (Thermo Scientific). 400 ng RNA
was reverse transcribed into cDNA using random hexamer primers with the RevertAid H
Minus First Strand cDNA Synthesis Kit (Thermo Scientific) following manufacturer’s proto-
col. Each qRT-PCR reaction contained 500 nM of each primer pair (Table 2), 10 ng of cDNA
and 1x iTaq universal SYBR green supermix (Bio-Rad). qRT-PCR reactions were conducted
on the Quantstudio 7 Flex real time PCR (Thermo Fischer) for 10 min at 95 ˚C, followed by 40
cycles of 15 sec at 95 ˚C and 30 sec at 60 ˚C. GAPDH was used as housekeeping gene. Data and
melting curves were analyzed using Quantstudio Real-time PCR software v1.3 and relative
expression compared to controls was calculated using the ΔΔCt method [50]. Significance was
calculated using an unpaired t-test.
Migration assay
The Boyden Chamber transwell migration assay was used to determine the migration rate
towards MCP-1 upon LY86 KD [51]. A polycarbonate membrane insert with a 5 μM pore size
(Cell Biolabs) was placed in a well of a 24-wells plate filled with 500 μl Accell delivery medium
supplemented with 0.5% BSA with or without 100 ng/ml human MCP-1 (Prospec). The insert
was filled with 100 μl Accell delivery medium supplemented with 0.5% BSA and 100,000 THP-
1 monocytes treated for 72h with LY68 siRNA or Green non-targeting siRNA. Cells were
placed in a humidified incubator with 5% CO2 at 37 ˚C. After 3h, the number of migratory
cells was quantified in the bottom well using a hemocytometer. Significance was calculated
using an unpaired t-test.
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Code availability
The original R code for Seurat [40] (https://github.com/satijalab/seurat), CellPhoneDB v2.0
[16] (https://github.com/Teichlab/cellphonedb) and our in-house eQTL pipeline [44] (https://
github.com/molgenis/ systemsgenetics/tree/master/eqtl-mapping-pipeline) can be found at
Github. All custom-made code is made available via GitHub (https://github.com/molgenis/
scRNA-seq).
Ethics statement
The LifeLines DEEP study was approved by the ethics committee of the University Medical
Center Groningen, document number METC UMCG LLDEEP: M12.113965. All participants
signed an informed consent form before study enrollment. All procedures performed in stud-
ies involving human participants were in accordance with the ethical standards of the institu-
tional and/or national research committee and with the 1964 Helsinki declaration and its later
amendments or comparable ethical standards.
Supporting information
S1 Fig. Relative cell type frequencies per donor. The relative cell type frequency per donor
(A) before and (B) after 24h Candida stimulation for each of the 6 cell types identified within
the peripheral blood mononuclear cells: B-cells, CD4+ and CD8+ T cells, monocytes, natural
killer (NK) cells and plasmacytoid dendritic cells (pDCs).
(TIF)
S2 Fig. Differentially expressed genes per cell type. The number of differentially expressed
(DE) genes per cell type (A) for all and (B) for the unique DE genes against the number of
cells.
(TIF)
S3 Fig. Bulk Candida-response QTLs visualized in single-cell RNA-seq data. 27 response
QTLs were identified in PBMC bulk RNA-seq data of 24h Candida-stimulated cells compared
to RPMI control cells. To pinpoint the cell type in which the response QTL effect could mani-
fest itself, PBMC single-cell RNA-seq data of 24h Candida-stimulated cells compared to RPMI
control cells was used. For 21 out of the 27 response QTL genes, expression was detected in the
single-cell RNA-seq data. The expression of individual cells was colored according to the con-
dition: red for stimulated and blue for RPMI control cells. The expression level is colored by
intensity, with gray cells having no expression.
(TIF)
S4 Fig. Regional association plot of the LY86 locus. Regional association plot of the LY86
locus (chr6;6088933–7155216, build hg19, ± 500 kb). P values on the -log10 scale are presented
as a function of the chromosomal position. The top enriched Candida-response QTL SNP
rs9405943 is presented as the red circle and the SNP rs2103635 showing the strongest associa-
tion to candidemia susceptibility is shown as the purple diamond. The correlations (r2) of each
Table 2. qRT-PCR primer sequences.
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of the surrounding SNPs to SNP rs2103635 are shown in the indicated colors. Recombination
rate is shown in pale blue.
(PDF)
S1 Table. Differential expression analysis upon Candida stimulation in single-cell as com-
pared to bulk RNA-seq data. Differentially expressed (DE) genes in the single-cell RNA-seq
(scRNA-seq) data of 24h Candida-stimulated cells as compared to RPMI control cells per cell
type separately and for all cells together (bulk-like). The first tab provides an overview of the
41 core genes that are DE in all cell types, including the Bonferroni-corrected p-value in each
of the cell types (p_val_adj). The p-value (p_val), average log fold change upon stimulation
(avg_logFC), the fraction stimulated (fraction.stim.exp) and unstimulated cells showing
expression (fraction.unstim.exp), the Bonferroni-corrected p-value (p_val_adj) and the
HGNC name (hgnc_names) are provided. The direction of the effect of the DE genes identi-
fied in scRNA-seq data are compared to the direction in bulk RNA-seq data (concordant),
unless not significant (n.s.) or not detected (NA). Additionally, the p-value (bulk.p.val) and t-
statistic (bulk.p.stat) within the bulk RNA-seq dataset are provided.
(XLSX)
S2 Table. Pathway enrichment analysis upon Candida stimulation in single-cell data. For
each cell type and for all cells together (bulk-like) the differentially expressed (DE) genes were
divided into up and down regulated genes. These were all separately used as input for a REAC-
TOME pathway analysis. The top10 enriched pathways are shown and p-values were Bonfer-
roni-corrected. Similarly, the 41 DE core genes that were identified in all cell types were used
as input for this analysis.
(XLSX)
S3 Table. Potential cell type-specific receptor-ligand interactions per condition (Candida
stimulation and RPMI control). P-values for all tested receptor-ligand interactions for the
RPMI control (first tab) and Candida stimulated PBMCs (second tab). An explanation of this
CellPhoneDB output file can be found at https://www.cellphonedb.org/documentation.
(XLSX)
S4 Table. Expression quantitative trait loci analysis upon Candida stimulation in bulk
RNA-seq data. eQTLs in bulk RNA-seq data in the Candida-stimulated (stimulated_eQTLS)
or RPMI control (unstimulated_eQTLs) condition. eQTLs for which the effect size before and
after Candida stimulation changes (response_QTLs_GWAS_annotated). The p-value (PVa-
lue), name (SNPName) and chromosome position (SNPChr, SNPChrPos) of the effect SNP,
affected gene (ProbeName), alleles to test (SNPType), allele to compare to (AlleleAssessed), Z-
score (OverallZScore), gene name (HGNCName), effect size with standard error (Beta.SE),
false discovery rate (FDR) and p-value in GWAS on candidemia susceptibility (gwas.pval).
(XLS)
S5 Table. Underlying numerical data for functional validation experiments. The underlying
numerical data for Figure panels 3E and 3F.
(XLSX)
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